Zsolt Hodi

2.9k total citations
43 papers, 2.0k citations indexed

About

Zsolt Hodi is a scholar working on Pathology and Forensic Medicine, Cancer Research and Surgery. According to data from OpenAlex, Zsolt Hodi has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pathology and Forensic Medicine, 24 papers in Cancer Research and 14 papers in Surgery. Recurrent topics in Zsolt Hodi's work include Breast Lesions and Carcinomas (26 papers), Breast Cancer Treatment Studies (22 papers) and Cancer and Skin Lesions (13 papers). Zsolt Hodi is often cited by papers focused on Breast Lesions and Carcinomas (26 papers), Breast Cancer Treatment Studies (22 papers) and Cancer and Skin Lesions (13 papers). Zsolt Hodi collaborates with scholars based in United Kingdom, Hungary and Spain. Zsolt Hodi's co-authors include Ian O. Ellis, Andrew H.S. Lee, Emad A. Rakha, Jorge S. Reis‐Filho, Roger W. Blamey, C.W. Elston, Maysa E. El‐Sayed, Desmond G. Powe, Matthew J. Grainge and Douglas Macmillan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The American Journal of Surgical Pathology.

In The Last Decade

Zsolt Hodi

37 papers receiving 2.0k citations

Peers

Countries citing papers authored by Zsolt Hodi

Since Specialization

Citations

This map shows the geographic impact of Zsolt Hodi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zsolt Hodi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zsolt Hodi more than expected).

Fields of papers citing papers by Zsolt Hodi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zsolt Hodi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zsolt Hodi. The network helps show where Zsolt Hodi may publish in the future.

Co-authorship network of co-authors of Zsolt Hodi

This figure shows the co-authorship network connecting the top 25 collaborators of Zsolt Hodi. A scholar is included among the top collaborators of Zsolt Hodi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zsolt Hodi. Zsolt Hodi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Should a borderline negative HER2 result in a core biopsy of invasive carcinoma of the breast have HER2 assessment repeated in the excision specimen? 2023 ·Journal of Clinical Pathology ·Andrew H.S. Lee, Zsolt Hodi, (unknown), (unknown), Ian O. Ellis, Emad A. Rakha	1
2	Second opinion (external specialist referral) practice of breast pathology: the Nottingham experience 2023 ·Histopathology ·Emad A. Rakha, (unknown), (unknown), Zsolt Hodi, Andrew H.S. Lee, Ian O. Ellis	5
3	Defining a threshold for tacrolimus intra-patient variability associated with late acute cellular rejection in paediatric kidney transplant recipients 2019 ·Pediatric Nephrology ·(unknown), (unknown), Zsolt Hodi, (unknown), (unknown), Martin Christian, Timothy J. Key, Jon Jin Kim	12
4	Pleomorphic adenoma‐like tumour of the breast 2015 ·Histopathology ·Emad A. Rakha, Mohammed A. Aleskandarany, Rehab Monir Samaka, Zsolt Hodi, Andrew H.S. Lee, Ian O. Ellis	12
5	The effect of delay in fixation on HER2 expression in invasive carcinoma of the breast assessed with immunohistochemistry and in situ hybridisation 2014 ·Journal of Clinical Pathology ·Andrew H.S. Lee, (unknown), (unknown), (unknown), Zsolt Hodi, Ian O. Ellis	13
6	Loss of Dicer expression is associated with breast cancer progression and recurrence 2012 ·Breast Cancer Research and Treatment ·(unknown), Emad A. Rakha, Tarek M. Abdel-Fatah, Christopher C. Nolan, Zsolt Hodi, Douglas Macmillan, Ian O. Ellis, Andrew R. Green	66
7	The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients 2012 ·Breast Cancer Research and Treatment ·(unknown), Emad A. Rakha, Tarek M. Abdel-Fatah, Christopher C. Nolan, Zsolt Hodi, R. Douglas Macmillan, Ian O. Ellis, Andrew R. Green	15
8	Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification: Table 1 2011 ·Journal of Clinical Pathology ·Andrew H.S. Lee, (unknown), (unknown), Zsolt Hodi, Ian O. Ellis	24
9	Expression of the tumour antigen T21 is up‐regulated in prostate cancer and is associated with tumour stage 2011 ·British Journal of Urology ·Amanda K. Miles, (unknown), Thomas A. McCulloch, Zsolt Hodi, Stéphanie McArdle, (unknown), Robert C. Rees	0
10	Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia 2011 ·Histopathology ·Emad A. Rakha, Bernard Ho, (unknown), (unknown), Lisa Hamilton, Zsolt Hodi, Ian O. Ellis, (unknown)	48
11	The prognostic significance of lymphovascular invasion in invasive breast carcinoma 2011 ·Cancer ·Emad A. Rakha, Stewart G. Martin, Andrew H.S. Lee, D.A.L. Morgan, Paul D.P. Pharoah, Zsolt Hodi, Douglas Macmillan, Ian O. Ellis	193
12	Functional and Histopathologic Changes in Renal Transplant Patients With New-Onset Diabetes and Dyslipidemia 2011 ·Transplantation Proceedings ·(unknown), Edit Szederkényi, Csaba Lengyel, Zita Morvay, (unknown), (unknown), (unknown), Tamás Takács, P. Szenohradszky, Zsolt Hodi, György Lázár	12
13	Comparison of margin assessment by radial and shave sections in wide local excision specimens for invasive carcinoma of the breast 2010 ·Histopathology ·Zsolt Hodi, Ian O. Ellis, C.W. Elston, Sarah E. Pinder, (unknown), R. Douglas Macmillan, Andrew H.S. Lee	8
14	The significance of lobular neoplasia on needle core biopsy of the breast 2008 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Sindhu Menon, (unknown), Andrew Evans, Ian O. Ellis, C.W. Elston, Zsolt Hodi, (unknown)	62
15	Morphologic and Molecular Evolutionary Pathways of Low Nuclear Grade Invasive Breast Cancers and Their Putative Precursor Lesions: Further Evidence to Support the Concept of Low Nuclear Grade Breast Neoplasia Family 2008 ·The American Journal of Surgical Pathology ·Tarek M. Abdel-Fatah, Desmond G. Powe, Zsolt Hodi, Jorge S. Reis‐Filho, Andrew H.S. Lee, Ian O. Ellis	160
16	Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) – an alternative to surgery in selected cases 2008 ·The Breast ·(unknown), A. Evans, Lisa Hamilton, Jonathan J. James, A.H.S. Lee, Zsolt Hodi, Ian O. Ellis, Emad A. Rakha, (unknown)	37
17	Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast 2007 ·Histopathology ·A H S Lee, Zsolt Hodi, Ian O. Ellis, C.W. Elston	103
18	High Frequency of Coexistence of Columnar Cell Lesions, Lobular Neoplasia, and Low Grade Ductal Carcinoma In Situ With Invasive Tubular Carcinoma and Invasive Lobular Carcinoma 2007 ·The American Journal of Surgical Pathology ·Tarek M.A. Abdel-Fatah, Desmond G. Powe, Zsolt Hodi, Andrew H.S. Lee, Jorge S. Reis‐Filho, Ian O. Ellis	184
19	The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast 2006 ·Journal of Clinical Pathology ·Zsolt Hodi, Jayeta Chakrabarti, Andrew H.S. Lee, J Ronan, C.W. Elston, Kwok‐Leung Cheung, J.F.R. Robertson, Ian O. Ellis	53
20	Pyogenic liver abscess - 20 years' experience 2002 ·Langenbeck s Archives of Surgery ·(unknown), József Hőhn, Zsolt Hodi, (unknown), Attila Balogh	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact